NEW YORK, Jan 8 – Caliper and Structural Genomix have agreed to jointly develop a high throughput protein analysis system that will run on Caliper’s Microfluidics technology platform, the companies announced Monday.
In the collaboration, the companies will combine Caliper’s LabChip microfluidics technology and Structural Genomix’s high throughput X-ray crystallography methods of characterizing proteins. The combined product will put Caliper’s protein sizing and analysis assay into an automated 96-well sipper chip that can process hundreds of protein samples per day.
This integrated microfluidics device, the companies said, will enable researchers to save the time and effort required by gel electrophoresis with a fast, automated and integrated system, designed to achieve high-level resolution to support highly precise purity analysis.
" Collaborations with leading technology developers such as Caliper will allow us to achieve our goal of bringing protein structure information to the forefront of the drug discovery process through leadership in technology development and integration,” Structural Genomix CEO Tim Harris said in a statement.